Domestic researchers have made significant progress toward developing artificial intelligence (AI)-based antibody drugs that ...

Optibrium, announced a new QuanSA™ plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of the Company’s BioPharmics 3D ...

The MarketWatch News Department was not involved in the creation of this content. Rapid, structure-free binding affinity prediction enables OpenFold3 to address key bottleneck in commercial ...

Despite significant progress in medicinal chemistry and life sciences research, drug discovery and development remain slow and expensive, taking on average approximately 15 years and US$2 billion to ...

Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used to treat diseases such as cancer by binding to specific targets, including ...

Drug discovery has not yet had its “ChatGPT moment,” according to Arman Zaribafiyan, PhD, head of product, AI simulation and platforms, at SandboxAQ, in an interview with GEN. “We can’t rely only on ...

A new research framework published in Engineering provides a structured, high-efficiency approach to innovative drug discovery from Chinese herbal ...

"AI-driven binding affinity prediction has evolved from a niche method to a core component of modern drug discovery workflows. SandboxAQ is proud to deliver this powerful capability to the consortium ...